In our cohort, mutations in BRAF, a major driver gene in CM [5], was significantly less frequent in MM than CM (12.2% vs 50%, Tables 1, 2, Fisher’s exact test, p < 0.001). This evidence concerns the gene BRAF and Miyoshi myopathy.